Futura Medical plc (AIM:FUM)

Market Cap	2.92M -75.4%
Revenue (ttm)	2.32M -70.8%
Net Income	-3.67M
EPS	-0.01
Shares Out	1.48B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,135,215
Open	0.2000
Previous Close	0.1960
Day's Range	0.1874 - 0.2100
52-Week Range	0.1800 - 4.4900
Beta	-0.00
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 2, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 13
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error